Search In this Thesis
   Search In this Thesis  
العنوان
Microalbuminuria is a marker of left
ventricular hypertrophy in hypertensive,
non diabetic, patients
المؤلف
Youssef,Hani Fakhry
هيئة الاعداد
باحث / Hani Fakhry Youssef
مشرف / Ramzy Hamed
مشرف / Ahmed Khashaba
مشرف / Bassem Wadee
الموضوع
Hypertension and the cardiovascular<br>system-
تاريخ النشر
2005
عدد الصفحات
201.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض القلب والطب القلب والأوعية الدموية
تاريخ الإجازة
1/1/2005
مكان الإجازة
جامعة عين شمس - كلية الطب - cardiology
الفهرس
Only 14 pages are availabe for public view

from 201

from 201

Abstract

The association between microalbuminuria and hypertension was
described a long time ago. Both microalbuminuria and left
ventricular hypertrophy may reflect target organ damage. We
studied the prevalence of left ventricular hypertrophy in ٦٠
hypertensive non diabetic patients, with microalbuminuria at the
period from December ٢٠٠٣ to August ٢٠٠٤. We found that ٦٥% of
all the patients had left ventricular hypertrophy, and ٥% had renal
parynchematus disease.
Microalbuminuria, defined as a urinary albumin excretion between
٣٠-٣٠٠ mg/٢٤ hours, was a strong predictor of left ventricular
hypertrophy.
For ١٢ weeks, ٣٠ patients were treated by ACE inhibitors (group
A) and the rest of the patients (group B) were treated by other
antihypertensive modalities.
We found that group (A) showed significant DROP in the level of
microalbuminuria and hence the degree of left ventricular
hypertrophy, with no changes in the kidney function, in comparison
to group (B).
So ACE inhibitors show their ability to control microalbuminuria
and decrease level of left ventricular hypertrophy, without affectation
of the kidney function, in comparison to other antihypertensive
drugs.
Key words: hypertension, microalbuminuria, left ventricular
hypertrophy, ACE inhibitors.